| Autor: |
Chamoieva AE; National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan., Mirmanova ZZ; National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan., Zhalbinova MR; National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan., Rakhimova SE; National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.; Eurasian Society of Personalized Medicine, Astana 010000, Kazakhstan., Daniyarov AZ; National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.; Faculty of Natural Sciences, L.N. Gumilyev, Eurasian National University, Astana 010008, Kazakhstan., Kairov UY; National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.; Eurasian Society of Personalized Medicine, Astana 010000, Kazakhstan., Baigalkanova AI; Corporate Fund 'University Medical Center', National Research Cardiac Surgery Center, Astana 010000, Kazakhstan., Mukarov MA; Corporate Fund 'University Medical Center', National Research Cardiac Surgery Center, Astana 010000, Kazakhstan., Bekbossynova MS; Corporate Fund 'University Medical Center', National Research Cardiac Surgery Center, Astana 010000, Kazakhstan., Akilzhanova AR; National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan.; Eurasian Society of Personalized Medicine, Astana 010000, Kazakhstan.; Faculty of Natural Sciences, L.N. Gumilyev, Eurasian National University, Astana 010008, Kazakhstan. |
| Abstrakt: |
Familial hypercholesterolemia is an autosomal hereditary disease defined by an increased level of low-density lipoprotein cholesterol (LDL-C), which predisposes significant risks for premature cardiovascular disorders. We present a family trio study: proband, a 13-year-old Kazakh girl with homozygous familial hypercholesterolemia (HoFH) and her parents. HoFH is much more rare and severe than a heterozygous form of the disorder. HoFH patients generally present with LDL-C levels exceeding 13 mmol/L, resulting in early and life-threatening cardiovascular events within the first decades of life. In cases of neglected treatment, young patients have a risk of death from coronary diseases before the age of 30. The aim of this research was to identify genetic mutations in the affected patient and her parents. Genetic testing was necessary due to highly elevated LDL-C levels and the presence of multiple xanthomas. Targeted next-generation sequencing (NGS) was performed in this study using the Illumina TruSight cardio panel, which targets 174 genes related to cardiac disorders. The girl was diagnosed with HoFH based on the results of genetic testing. A biallelic mutation was observed in exon 3 of the low-density lipoprotein receptor ( LDLR ): c. 295 G>A (p.Glu99Lys). Sanger sequencing confirmed that the mutant gene was inherited from both parents. After confirming the genetic diagnosis of HoFH, the patient was treated with LDL apheresis and statins. This case report is the first study of HoFH in a pediatric patient from the Central Asian region. Globally, it emphasizes the need for increased clinical awareness among healthcare providers, as early detection and intervention are important for improving outcomes, particularly in pediatric patients with this rare genetic disorder. |
